Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Assessing DDI Risk in the Digital Age
Posted on August 9th, 2017 by Sherry Winter in Pharmacovigilance
In their 2012 Drug Regulations, the U.S. Food and Drug Administration recommended that “pharmacokinetic interactions between an investigational new drug and other drugs should be defined during drug development.”
The Eternal Triangle of Quality, Speed, and Cost
Posted on August 7th, 2017 by Dr Andrew A. Parsons in Pharma R&D
A designer colleague once described to me the key issue involved in many of their creative design projects. It is finding the best balance between quality, speed, and cost. From a buyer perspective, we desire high quality, rapid delivery, and low cost. (more…)
A New Innovative Approach: Application of Digital Healthcare
Posted on August 4th, 2017 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
Just last week, US FDA Commissioner Dr. Scott Gottlieb published a blog on the FDA web site that talks about new policies the FDA is going to be acting upon. These new policies are designed to empower the consumer to act on his own and allow ‘digital healthcare’ technologies to help promote better health. (more…)
Creating a Formula for Precise, Effective Literature Searching
Posted on July 31st, 2017 by Neal Katz in Pharmacovigilance
Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. (more…)
